All Resources
App Note
Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus Using the Opto™ Viral Neutralization 1.0 Workflow

Learn how to use blocking and binding assays and the Opto Viral Neutralization 1.0 workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

Discover blocking antibodies against SARS-CoV-2 in 1 day.
Find cross-reactive antibodies against SARS-CoV-1 and SARS-CoV-2.
Confirm binding and blocking of SARS-CoV-2 in plate-based functional assays.
A Deeper Look

More about this App Note

Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2

In this application note, we describe how the Opto Viral Neutralization 1.0 workflow can be used to rapidly select functional antibodies against SARS-CoV-2. Download to learn more and review the case studies.

Get the App Note